Hsiao E I, Kirsch C M, Kagawa F T, Wehner J H, Jensen W A, Baxter R B
Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, 300 Pasteur Dr., Stanford, CA 94305, USA.
AJR Am J Roentgenol. 2001 Oct;177(4):861-7. doi: 10.2214/ajr.177.4.1770861.
We wanted to investigate the utility of performing fiberoptic bronchoscopy before bronchial artery embolization in patients with massive hemoptysis.
We retrospectively reviewed the cases of all patients with hemoptysis who had presented at either of two local hospitals, one county hospital and one community hospital, between 1988 and 2000 and who had undergone fiberoptic bronchoscopy before bronchial arteriography. All data were abstracted using a standardized coding form, and radiographs were independently reviewed by two of the authors.
Twenty-nine patients meeting the inclusion criteria were identified; one patient was excluded because of missing radiographs. The remaining 28 patients consisted of 19 men and nine women, with an average age of 54.6 years (age range, 16-91 years). The clinically determined diagnoses of their symptoms were tuberculous bronchiectasis (n = 14; 50.0%); bronchogenic carcinoma (n = 4; 14.3%); active tuberculosis (n = 2; 7.1%); nontuberculous bronchiectasis (n = 2; 7.1%); active coccidioidomycosis, pancreaticobronchial fistula, arteriovenous malformation, and tetralogy of fallot (n =1 each; 3.6% each); and unknown cause (n = 2; 7.1%). The bleeding site determined through bronchoscopy was consistent with that determined through radiographs in 23 patients (82.1%); all had either unilateral disease (n = 15), bilateral disease with unilateral cavities (n = 5), or a preponderance of disease on one side (n = 3). Bronchoscopy was an essential tool in determining the bleeding site in only three patients (10.7%), all of whom had bronchiectasis without localizing features visible on chest radiographs. In the remaining two patients (7.1%), bronchoscopic findings were indeterminate, but radiographs were helpful.
Fiberoptic bronchoscopy before bronchial artery embolization is unnecessary in patients with hemoptysis of known causation if the site of bleeding can be determined from radiographs and no bronchoscopic airways management is needed.
我们想要研究在大量咯血患者中,在支气管动脉栓塞术前进行纤维支气管镜检查的效用。
我们回顾性分析了1988年至2000年间在两家当地医院(一家县医院和一家社区医院)就诊的所有咯血患者的病例,这些患者在支气管动脉造影术前接受了纤维支气管镜检查。所有数据均使用标准化编码表格提取,X光片由两位作者独立审查。
确定了29例符合纳入标准的患者;1例患者因X光片缺失被排除。其余28例患者包括19名男性和9名女性,平均年龄54.6岁(年龄范围16 - 91岁)。根据临床症状确定的诊断为结核性支气管扩张(n = 14;50.0%);支气管源性癌(n = 4;14.3%);活动性肺结核(n = 2;7.1%);非结核性支气管扩张(n = 2;7.1%);活动性球孢子菌病、胰支气管瘘、动静脉畸形和法洛四联症(各n = 1;各3.6%);以及病因不明(n = 2;7.1%)。通过支气管镜检查确定的出血部位与通过X光片确定的出血部位在23例患者(82.1%)中一致;所有患者均为单侧疾病(n = 15)、双侧疾病伴单侧空洞(n = 5)或一侧病变占优势(n = 3)。支气管镜检查仅在3例患者(10.7%)中是确定出血部位的必要工具,所有这些患者均患有支气管扩张且胸部X光片上无定位特征。在其余2例患者(7.1%)中,支气管镜检查结果不明确,但X光片有帮助。
对于已知病因的咯血患者,如果出血部位可通过X光片确定且无需支气管镜气道管理,则在支气管动脉栓塞术前无需进行纤维支气管镜检查。